Should Weight Management Be a Primary Treatment Goal for Type 2 Diabetes?
Presenter: James R Gavin III, MD, PhD (Emory University School of Medicine)
No relevant financial relationships

Should Weight Management Be a Primary Treatment Goal for Type 2 Diabetes?
Presenter: David M Nathan, MD (HARVARD MEDICAL SCHOOL)
No relevant financial relationships

Should Weight Management Be a Primary Treatment Goal for Type 2 Diabetes?
Presenter: Ildiko Lingvay (UT Southwestern Medical Center)
Relationship: Commercial Interest(s)
  Advisory Board Member: AstraZeneca
  Advisory Board Member: Bayer Inc.
  Advisory Board Member: Boehringer Ingelheim
  Advisory Board Member: Eli Lilly & Company
  Advisory Board Member: Intarcia
  Advisory Board Member: Lilly USA LLC
  Advisory Board Member: Mannkind Corporation
  Advisory Board Member: Merck
  Advisory Board Member: Novo Nordisk
  Advisory Board Member: Sanofi
  Advisory Board Member: Other (fill in the blank below)
  Advisory Board Member: Zealand Pharma
  Consulting Fee: Johnson & Johnson
  Consulting Fee: Novo Nordisk
  Consulting Fee: Other (fill in the blank below)
  Consulting Fee: Valeritas
  Grant Recipient: Merck
  Grant Recipient: Novo Nordisk
  Grant Recipient: Sanofi
  Grant Recipient: Other (fill in the blank below)
  Grant Recipient: Mylan